Outcome measures in haemophilia: more than just factor levels.
Bohn
R L
RL
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, USA.
Schramm
W
W
Bullinger
M
M
van den Berg
M
M
Blanchette
V
V
D001779:Blood Coagulation Factors / Q000191:economics / Q000378:metabolism* / Q000627:therapeutic use; D003226:Congresses as Topic; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D006467:Hemophilia A / Q000097:blood / Q000191:economics / Q000517:prevention & control*; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D011788:Quality of Life; D012449:Safety; D016896:Treatment Outcome
D001779:Blood Coagulation Factors